000			02196 a2200637 4500
005			20250515051317.0
264		0	_c20070522
008			200705s 0 0 eng d
022			_a0344-5704
024	7		_a10.1007/s00280-006-0393-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aChang, Yong S
245	0	0	_aSorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _cApr 2007
300			_a561-74 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aActins _xmetabolism
650	0	4	_aAdenocarcinoma, Clear Cell _xblood supply
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzenesulfonates _xtherapeutic use
650	0	4	_aCapillaries _xpathology
650	0	4	_aCell Line, Tumor
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypoxia _xchemically induced
650	0	4	_aImmunohistochemistry
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aKidney Neoplasms _xblood supply
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aPlatelet Endothelial Cell Adhesion Molecule-1 _ximmunology
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aRegional Blood Flow _xdrug effects
650	0	4	_aSorafenib
650	0	4	_aVascular Endothelial Growth Factor A _xmetabolism
700	1		_aAdnane, Jalila
700	1		_aTrail, Pamela A
700	1		_aLevy, Joan
700	1		_aHenderson, Arris
700	1		_aXue, Dahai
700	1		_aBortolon, Elizabeth
700	1		_aIchetovkin, Marina
700	1		_aChen, Charles
700	1		_aMcNabola, Angela
700	1		_aWilkie, Dean
700	1		_aCarter, Christopher A
700	1		_aTaylor, Ian C A
700	1		_aLynch, Mark
700	1		_aWilhelm, Scott
773	0		_tCancer chemotherapy and pharmacology _gvol. 59 _gno. 5 _gp. 561-74
856	4	0	_uhttps://doi.org/10.1007/s00280-006-0393-4 _zAvailable from publisher's website
999			_c16729144 _d16729144